CFTR modulation has changed the landscape and quality of life for many individuals with cystic fibrosis (CF), and specialized understanding of its impact outside of lung function has not always been well-characterized. This session will focus on the impacts of CFTR modulation on the gastrointestinal and nutritional aspects of CF care, including emerging approaches to new treatments on the horizon. Furthermore, from a practical standpoint, this session will also take time to consider how to approach patients regarding the role and necessity of other aspects of CF care that may come into question depending on an individual's clinical response to modulation.
Examine the impacts of CFTR modulation on the gastrointestinal and nutritional health of individuals with CF, and discuss common GI side effects and drug interactions associated with modulator use.
Compare and contrast impacts from emerging 'triple-therapy', and discuss potential clinical outcomes of interested related to ongoing research.
Discuss strategies regarding how to communicate with patients/caregivers about the ongoing role of other CF therapies in the context of CFTR modulation.